Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®ÀÇ ¼º°ø·ü¿¡ °üÇÑ ÀüÇâÀû Àӻ󿬱¸

A Prospective Clinical Trial on the Mg Oxidized Clinical Implants

±¸°­È¸º¹ÀÀ¿ë°úÇÐÁö 2011³â 27±Ç 1È£ p.25 ~ 39
ÀÓ¼Ò¹Î, ±è´ë°ï, ¹ÚÂùÁø, Á¶¸®¶ó, ¾öÈï½Ä, ÀÌÀç°ü,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀӼҹΠ( Im So-Min ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
±è´ë°ï ( Kim Dae-Gon ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
¹ÚÂùÁø ( Park Chan-Jin ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
Á¶¸®¶ó ( Cho Lee-Ra ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
¾öÈï½Ä ( Um Heung-Sik ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
ÀÌÀç°ü ( Lee Jae-Kwan ) - °­¸ª¿øÁÖ´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç

Abstract

¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®´Â µ¿¹°½ÇÇè¿¡¼­ ¿ì¼öÇÑ °ñ¹ÝÀÀÀ» ³ªÅ¸³»¾úÁö¸¸ ÀÌ¿¡ ´ëÇÑ ÀÓ»ó ¿¬±¸´Â Àü¹«ÇÏ´Ù. º» ¿¬±¸¿¡¼­´Â ¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®ÀÇ ´Ü±â°£ ¼º°ø·ü ¹× ¾ÈÁ¤¼º, º¯¿¬°ñ Èí¼ö·®À» Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù. °­¸ª¿øÁÖ´ëÇб³ Ä¡°úº´¿øÀÇ ÀÓ»ó½ÃÇèÀ§¿øȸÀÇ ½ÂÀÎÀ» °ÅÃÄ °Ç°­ÇÑ ºÎºÐ ¹«Ä¡¾Ç ȯÀÚ¿¡°Ô ¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®¸¦ ½Ä¸³ÇÑ ÈÄ ÀϹÝÀûÀÎ ÇÁ·ÎÅäÄÝ¿¡ µû¶ó º¸Ã¶ Ä¡·á¸¦ ½ÃÇàÇÏ¿´´Ù. 1Â÷ ¼ö¼ú, 2Â÷ ¼ö¼ú, º¸Ã¶¹° ½ÃÀû, ÇÏÁß ÈÄ 1°³¿ù, 3°³¿ù, 6°³¿ù Æò°¡¸¦ ½ÃÇàÇÏ¿´À¸¸ç, ¸Åȸ ³»¿ø ½Ã ÀÓÇöõÆ® ¾ÈÁ¤Áö¼ö(Implant stability quotient, ISQ)¸¦ ÃøÁ¤ÇÏ°í ±¸³» Ä¡±Ù´Ü ¹æ»ç¼± »çÁø¿¡¼­ º¯¿¬°ñ Èí¼ö·®À» »êÃâÇÏ¿´´Ù. ¹Ýº¹ÃøÁ¤ÀÌ ÀÖ´Â ºÐ»êºÐ¼®¹ýÀ» ÀÌ¿ëÇÏ¿© Åë°èÀû ºÐ¼®À» ½ÃÇàÇÏ¿´´Ù. ÃÑ 50¸í¿¡°Ô ½Ä¸³µÈ 101°³ÀÇ ÀÓÇöõÆ® Áß °ñÀ¯Âø¿¡ ½ÇÆÐÇÑ ÀÓÇöõÆ®´Â ¾ø¾úÀ¸¸ç, ÇÏÁß ÈÄ 6°³¿ù ¼º°ø·üÀº 100% ¿´´Ù. Æò±Õ ISQ´Â ½Ã°£ÀÌ °æ°úÇÔ¿¡ µû¶ó Áõ°¡ÇÏ¿´À¸¸ç ¿©¼ºº¸´Ù ³²¼º¿¡¼­, »ó¾Çº¸´Ù ÇϾǿ¡¼­ ³ô°Ô ³ªÅ¸³µ´Ù (P<.05). ÇÏÁß 6°³¿ù ÈÄ °ñÁúÀÌ ¾çÈ£ÇÒ¼ö·Ï, °íÁ¤Ã¼ Á÷°æÀÌ Å¬¼ö·Ï ³ôÀº ISQ °ªÀ» º¸¿´´Ù (P<.05). ÇÏÁß ÈÄ 6°³¿ù°£ Æò±Õ º¯¿¬°ñ Èí¼ö·®Àº 0.26 mm·Î °üÂûµÇ¾úÀ¸¸ç ÇϾǺ¸´Ù »ó¾Ç¿¡¼­, ¿©¼ºº¸´Ù ³²¼º¿¡¼­ ´õ ¸¹Àº Èí¼ö°¡ °üÂûµÇ¾ú´Ù. º» ¿¬±¸ÀÇ ¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®ÀÇ 6°³¿ù ¼º°ø·üÀº 100%À̸ç, ³·Àº °ñÁú¿¡¼­µµ ¿ì¼öÇÑ °ñÀ¯ÂøÀÌ °üÂûµÇ¾ú´Ù. ¾ÈÁ¤¼º°ú º¯¿¬°ñ ¼öÁØ ¶ÇÇÑ ¸¸Á·½º·¯¿î °á°ú¸¦ º¸¿´Áö¸¸ ´õ¿í Àå±âÀûÀÎ Àӻ󿬱¸°¡ ÇÊ¿äÇÏ´Ù°í »ç·áµÈ´Ù.

In animal studies, Magnesium (Mg) - incorporated oxidized implants showed significant enhancement of the bone response. This prospective clinical trial was performed to investigate the success rate, implant stability and marginal bone loss of Mg oxidized clinical implant.The experimental protocol was approved by Institutional Review Board of the Gangneung-Wonju National University Dental Hospital. Fifty healthy patients had partial edentulism were included in this study. Mg oxidized clinical implants (Implant M, Shinhung, Korea) were installed and restored with conventional protocol. The patients were recalled at 1, 3, 6 months after functional loading. Implant stability quotient (ISQ) was measured and periapical radiographic images were obtained. Amount of marginal bone loss was calculated with calibrated images from periapical radiographs. Repeated measured analysis of variance and post hoc Tukey test were used to compare the mean ISQ and bone level. A total of 101 implants were analyzed. The mean ISQ values increased continuously with time lapse from 68.4 at fixture installation to 71.5 at 6 months after loading. Implant stability was correlated with gender, fixture diameter, bone quality and implant sites. The mean marginal bone loss during 6 months after loading was 0.26 mm. There was no failed implant and six-month success rate was 100%. Within the limitations of this study, the six-month success rate of Mg oxidized implant was satisfactory. The implant stability and marginal bone level were excellent. However, further longer clinical studies will be needed to confirm the success of Mg oxidized clinical implant. Key words: ISQ, magnesium oxidized implant,

Å°¿öµå

¸¶±×³×½· ¾ç±Ø»êÈ­ ÀÓÇöõÆ®;º¯¿¬°ñ Èí¼ö;¼º°ø·ü;ÀÓÇöõÆ® ¾ÈÁ¤ Áö¼ö;ÀüÇâÀû ÀÓ»ó ¿¬±¸
ISQ;magnesium oxidized implant;marginal bone loss;prospective clinical trial;success rate

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI